Nanopublication

< Home

ID

http://purl.org/np/RA-Q8OR6_xjIlVC0A0Z8oz1L-rktMyTGunyUFlhPxj2ac

Formats

.trig | .trig.txt | .jelly | .jelly.txt

Content

@prefix this: <http://purl.org/np/RA-Q8OR6_xjIlVC0A0Z8oz1L-rktMyTGunyUFlhPxj2ac> .
@prefix sub: <http://purl.org/np/RA-Q8OR6_xjIlVC0A0Z8oz1L-rktMyTGunyUFlhPxj2ac#> .
@prefix drugbank: <http://identifiers.org/drugbank/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix pav: <http://purl.org/pav/> .
@prefix infores: <https://w3id.org/biolink/infores/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ntemplate: <https://w3id.org/np/o/ntemplate/> .
@prefix orcid: <https://orcid.org/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix pmid: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix ncit: <http://purl.obolibrary.org/obo/NCIT_> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubInfo .
}

sub:assertion {
  drugbank:DB00273 a biolink:Drug;
    rdfs:label "Topiramate";
    biolink:category biolink:Drug .
  
  <http://purl.obolibrary.org/obo/DOID_1574> a biolink:Disease;
    rdfs:label "alcohol use disorder";
    biolink:category biolink:Disease .
  
  sub:association a biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
    rdf:object <http://purl.obolibrary.org/obo/DOID_1574>;
    rdf:predicate biolink:treats;
    rdf:subject drugbank:DB00273;
    rdfs:label "It has been tested in multiple clinical trials since it could be promising in AUD treatment. Topiramate decreases reinforcing effects of alcohol and craving. A meta-analysis, based on data from seven random studies (2003-2014), suggested that topiramate might have beneficial effects in AUD treatment but because of its many side effects, the use is limited. The most common side effects are cognitive dysfunction, paresthesia, and taste abnormalities.";
    biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
    biolink:category biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
    biolink:has_population_context sub:context;
    biolink:publications pmid:29912214;
    biolink:relation ncit:C94303 .
  
  sub:context a biolink:Cohort;
    rdfs:label "adults";
    biolink:category biolink:Cohort .
}

sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0002-7641-6446 .
}

sub:pubInfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB";
    npx:hasSignature "UHV/mWJ/aaTQvaW8DtB2T7uqTzMs/A5eJFt0LFsdGsIukNb6MkCqfq4Fsg2Bc6aUViEeuFLminLuKe8fPkiKyBMh4BgBGkEaEm+J1+K6utMFazSitn3CyllCJpmGz3JHjdvx1Z3n7oAJiN9GE7uWdcQFlB9tfueqxWvWq6fGi0M=";
    npx:hasSignatureTarget this: .
  
  this: prov:generatedAtTime "2022-09-16T11:54:28.861339"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-1501-1082;
    ntemplate:wasCreatedFromTemplate <http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY> .
  
  biolink: pav:version "2.3.0" .
}